FGF21 and metabolic syndrome: In this study, we also incorporated plasma biomarkers traditionally used to study and diagnose metabolic and mitochondrial disorders, such as fibroblast growth factor 21 (FGF21), also linked to metabolic syndrome [43,44,45], and coenzyme Q10 (CoQ), both potential surrogates of MRC dysfunction [46].